Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease

Anti- tumor Necrosis Factor (anti-TNF) agents are the backbone treatment of moderate to severe cases of inflammatory bowel disease. One of the main drawbacks of these agents is the high cost. The introduction of biosimilar products to anti-TNF agents is expected to lower the cost. Health care provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Sulais, Eman, AlAmeel, Turki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966952/
https://www.ncbi.nlm.nih.gov/pubmed/32021084
http://dx.doi.org/10.2147/BTT.S236433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966952/
https://www.ncbi.nlm.nih.gov/pubmed/32021084
http://dx.doi.org/10.2147/BTT.S236433

Ejemplares similares